Literature DB >> 25644943

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.

Philipp Schwabl1,2, Theresa Bucsics1,2, Kathrin Soucek1,2, Mattias Mandorfer1,2, Simona Bota1,2, Alexander Blacky3, Alexander M Hirschl3, Arnulf Ferlitsch1,2, Michael Trauner1, Markus Peck-Radosavljevic1,2, Thomas Reiberger1,2.   

Abstract

BACKGROUND: Patients with ascites are at risk for developing spontaneous bacterial peritonitis (SBP) - a severe complication associated with high mortality. We aimed to identify risk factors for SBP development and mortality to optimize stratification for primary prophylaxis and therapeutic strategies to improve survival.
METHODS: 575 patients with cirrhosis and ascites undergoing paracentesis at a tertiary care hospital were included in this retrospective cohort study. Demographical, clinical and laboratory parameters were recorded at first paracentesis and during follow-up. Multivariate logistic regression analysis was used to identify independent predictors of SBP development and mortality.
RESULTS: Child-Pugh stage C (OR: 3.323; P = 0.009), ascitic fluid polymorph-nuclear cell (PMN) count (OR: 1.544; P = 0.028) and low serum sodium (OR: 0.917; P = 0.029) emerged as independent risk factors for SBP development. SBP-naïve patients undergoing paracentesis and presenting with PMN-counts ≥100 cells/μl, or hyponatraemia <125 mM were at highest risk for developing SBP. Increases in MELD and CRP levels indicated SBP development, while no changes where observed in a matched control group with sterile ascites at multiple paracenteses. MELD score (OR: 1.565; P = 0.001) and CRP (OR: 1.067; P = 0.037) were identified as independent risk factors for 30-day mortality after SBP diagnosis. In particular SBP patients with MELD≥22, CRP ≥3.5 mg/dl and development of grade III/IV hepatic encephalopathy showed highest mortality.
CONCLUSIONS: Low serum sodium levels, Child-Pugh stage C and elevated ascites PMN counts (≥100 cells/μl) indicate a significant risk for SBP development. SBP-related mortality is highest in patients with MELD≥22 and elevated CRP levels.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ascites; cirrhosis; development; mortality; risk factors; spontaneous bacterial peritonitis

Mesh:

Substances:

Year:  2015        PMID: 25644943     DOI: 10.1111/liv.12795

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  32 in total

Review 1.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

2.  Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.

Authors:  Philipp Lutz; Felix Goeser; Dominik J Kaczmarek; Stefan Schlabe; Hans Dieter Nischalke; Jacob Nattermann; Achim Hoerauf; Christian P Strassburg; Ulrich Spengler
Journal:  Dig Dis Sci       Date:  2017-06-09       Impact factor: 3.199

3.  Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.

Authors:  Benedikt Simbrunner; Annika Röthenbacher; Helmuth Haslacher; David Bauer; David Chromy; Theresa Bucsics; Philipp Schwabl; Rafael Paternostro; Bernhard Scheiner; Michael Trauner; Mattias Mandorfer; Ilse Schwarzinger; Thomas Reiberger
Journal:  United European Gastroenterol J       Date:  2019-04-05       Impact factor: 4.623

Review 4.  Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.

Authors:  Meng Zhang; Wei Liu; Xin Xu; Tao Chen; Jun-Ying Qi
Journal:  Curr Med Sci       Date:  2022-07-23

5.  Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Meng Zhang; Xin Xu; Wei Liu; Zhongwei Zhang; Qiuyu Cheng; Zhongyuan Yang; Tingting Liu; Yunhui Liu; Qin Ning; Tao Chen; Junying Qi
Journal:  Adv Ther       Date:  2021-07-25       Impact factor: 3.845

Review 6.  The Changing Role of Sodium Management in Cirrhosis.

Authors:  Blanca Lizaola; Alan Bonder; Elliot B Tapper; Angela Mendez-Bocanegra; Andres Cardenas
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

7.  The role of TIPS in the management of liver transplant candidates.

Authors:  Lukas W Unger; Theresa Stork; Theresa Bucsics; Susanne Rasoul-Rockenschaub; Katharina Staufer; Michael Trauner; Svenja Maschke; Max Pawloff; Thomas Soliman; Thomas Reiberger; Gabriela A Berlakovich
Journal:  United European Gastroenterol J       Date:  2017-04-07       Impact factor: 4.623

8.  Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.

Authors:  Edmondo Falleti; Sara Cmet; Anna R Cussigh; Elena Salvador; Davide Bitetto; Ezio Fornasiere; Elisa Fumolo; Carlo Fabris; Pierluigi Toniutto
Journal:  J Clin Exp Hepatol       Date:  2020-09-06

9.  Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.

Authors:  Benedict Kinny-Köster; Michael Bartels; Susen Becker; Markus Scholz; Joachim Thiery; Uta Ceglarek; Thorsten Kaiser
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

10.  Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.

Authors:  Nikolaj Torp; Mads Israelsen; Bjørn Madsen; Philipp Lutz; Christian Jansen; Christian Strassburg; Christian Mortensen; Anne Wilkens Knudsen; Grith Lykke Sorensen; Uffe Holmskov; Anders Schlosser; Maja Thiele; Jonel Trebicka; Aleksander Krag
Journal:  JHEP Rep       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.